Celgene Acquires Abraxis In $2.9 Billion Deal
Celgene has acquired Abraxis BioScience in a cash-and-stock deal valued at $2.9 billion, reports FierceBiotech.
News
OneMedForum to Highlight the Newest, Most Promising Med Tech Innovations
OneMedPlace announced that it will showcase to investors and entrepreneurs the newest and most promising new medical technologies in the region.
Special Session On Health Savings Accounts at OneMedForum New York 2010
Health Savings Accounts have been a central part of healthcare reform plans under both the Bush and Obama administrations, touted as a way for consumers to save on medical costs. But how will they be affected by the healthcare reform bill passed in March?
Implantable Prosthetics
The company has developed a novel thin film metal surface technology that can be used to synthesize advanced implantable prosthetics. This technology is currently used […]
Cancer Therapeutics
The company is a medical devices company that has developed a novel technology for site directed, electronic driven radiation therapy for the treatment of cancer. […]
Blindness, Retinal Implant
The company is a medical devices company that is developing a fully functioning electronic retinal implant to restore partial vision in blind patients. The company’s […]
Intravenous Drug Delivery
The company is a medical devices company that has developed a technology to provide safer intravenous drug delivery. The company’s product uses drug sensors, signal […]
Hearing and Balance Disorders
The company is a medical devices company that has built a technological platform using electrical energy to treat balance and hearing problems, including tinnitus where […]
Endoscopic Diagnostics
The company is a medical devices company that has developed an adjunct apparatus for facilitating endoscopic diagnostic procedures. A major difficulty with current endoscopic procedures […]
Heart Failure
The company is a medical devices company that has developed an innovative implantable apparatus for the treatment of heart failure. Heart failure is characterized by […]